4-aminopyridine Treatment for Nerve Injury — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

4-aminopyridine Treatment for Nerve Injury — Stella

Recruiting

Back to Nerve Injury trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

University of Arizona, Tucson, Arizona

University of Rochester, Rochester, New York

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

John Elfar

Enrollment target

~70 participants

Started

June 2021

Primary completion

July 2027

Age range

45 Years – 75 Years

Sex

Male only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov